Dhanuka Agritech
Dhanuka Agritech Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
The company expects a small single-digit growth in crop protection volumes for FY 2027, indicating a relatively flat to modest increase in sales. Management projects a small single-digit growth in crop protection volumes for FY 2027 despite challenges like monsoon deficit and delayed sowing. - Revenue growth guidance for FY 2027 has been cut steeply due to uncertain monsoon and weak demand in Q1 and early Q2. - There is optimism for improved sowing and revenue pickup in Q2 and Q3, but overall FY 2027 top-line growth is expected to be modest. - EBITDA breakeven at Dahej plant appears difficult this year, with expected negative EBITDA of around Rs.
From Dhanuka Agritech's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- The company expects a small single-digit growth in crop protection volumes for FY 2027, indicating a relatively flat to modest increase in sales.
- Growth projections have been revised downward due to monsoon delays and associated impact on sowing and demand.
- Despite a weaker 1Q impacted by delayed monsoon and lower sowing, recovery is anticipated in 2Q and 3Q as sowing catches up in some regions.
- Demand is expected to remain strong in irrigated areas (about 60% of Indian agriculture), with higher crop protection investments there.
- The bio-stimulant category is being reworked as a fallback and growth area under stress conditions; detailed guidance to be shared later.
- The company anticipates market share gains as smaller/unorganized players face regulatory challenges, benefiting organized players like Dhanuka.
- Bayer product revenues and international expansion are expected to contribute gradually, but exact numbers remain unspecified.
Profitability & Margins
See what Dhanuka Agritech said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has acquired land at Butibori industrial zone, Nagpur, Maharashtra for a new manufacturing plant.
- The Nagpur plant will be a formulation facility with an estimated CAPEX of around Rs. 200 crore.
- Proposed capacity of the Nagpur plant is 23,000 metric tons per annum.
- Expected commissioning timeline for the Nagpur plant is Q4 FY 2028 (around April 2028).
- The Nagpur facility will feature significant automation to enhance safety and efficiency.
- The plant has potential for future expansion beyond the initial 23,000 tons capacity.
- CAPEX of around Rs. 100 crore related to Nagpur is planned across FY 2027 and FY 2028.
- No overlapping formulation facility is planned at the Dahej chemical synthesis site due to technology and operational differences.
- Additional CAPEX for Dahej will be communicated later.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Dhanuka Agritech said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Dhanuka Agritech — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹483 Cr, net profit ₹98 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Dhanuka Agritech Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Indogulf Cropsciences Ltd (Q1 FY27)
1800+ crores within 2-3 years. Key concall takeaways from Indogulf Cropsciences Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Gujarat State Fertilizers & Chemicals Ltd (Q1 FY27)
Profit after tax increased by 15% YoY in Q1 FY27, signaling positive growth trajectory. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's…
- GSP Crop Science Ltd (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
- Rallis India Ltd (Q1 FY27)
. Key concall takeaways from Rallis India's Q1 FY27 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Dhanuka Agritech Q1 FY27 results?
The company expects a small single-digit growth in crop protection volumes for FY 2027, indicating a relatively flat to modest increase in sales. Management projects a small single-digit growth in crop protection volumes for FY 2027 despite challenges like monsoon deficit and delayed sowing. - Revenue growth guidance for FY 2027 has been cut steeply due to uncertain monsoon and weak demand in Q1 and early Q2. - There is optimism for improved sowing and revenue pickup in Q2 and Q3, but overall FY 2027 top-line growth is expected to be modest. - EBITDA breakeven at Dahej plant appears difficult this year, with expected negative EBITDA of around Rs.
What is Dhanuka Agritech share price analysis?
Dhanuka Agritech currently shows a neutral. The stock trades at a P/E of 16.3 with a market cap of ₹4,370 Cr. Investors should review the full earnings analysis for detailed insights.
Is Dhanuka Agritech planning capital expenditure?
The company has acquired land at Butibori industrial zone, Nagpur, Maharashtra for a new manufacturing plant. - The Nagpur plant will be a formulation facility with an estimated CAPEX of around Rs.
Keep Dhanuka Agritech on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.